Switching antidepressants after a first selective serotonin reuptake inhibitor in major depressive disorder: a systematic review.

@article{Ruh2006SwitchingAA,
  title={Switching antidepressants after a first selective serotonin reuptake inhibitor in major depressive disorder: a systematic review.},
  author={H. Ruh{\'e} and J. Huyser and J. Swinkels and A. Schene},
  journal={The Journal of clinical psychiatry},
  year={2006},
  volume={67 12},
  pages={
          1836-55
        }
}
  • H. Ruhé, J. Huyser, +1 author A. Schene
  • Published 2006
  • Medicine, Psychology
  • The Journal of clinical psychiatry
    • OBJECTIVE Selective serotonin reuptake inhibitors (SSRIs) are frequently used as a first antidepressant for major depressive disorder but have response rates of 50% to 60% in daily practice. For patients with insufficient response to SSRIs, switching is often applied. This article aims to systematically review the evidence for switching pharmacotherapy after a first SSRI. DATA SOURCES A systematic literature search (updated until Feb. 10, 2005) in MEDLINE, EMBASE, CINAHL, and PsychINFO (all… CONTINUE READING
    View PDF
    Top 3 of 198 Citations
    Pharmacologic approaches to treatment resistant depression: Evidences and personal experience.
    A. Tundo, R. de Filippis, L. ProiettiWorld journal of psychiatry2015
    39
    Sertraline treatment of patients with major depressive disorder who failed initial treatment with paroxetine or fluvoxamine
    T. Inoue, Minoru Honda, … T. KoyamaProgress in Neuro-Psychopharmacology and Biological Psychiatry2012
    4
    Pharmacy and medical costs associated with switching between venlafaxine and SSRI antidepressant therapy for the treatment of major depressive disorder.
    R. Khandker, D. Kruzikas, T. MclaughlinJournal of managed care pharmacy : JMCP2008
    26
    198 Citations
    Fields of Study

    Fields of Study

    Citation Type

    Citation Type

    Pharmacologic approaches to treatment resistant depression: Evidences and personal experience.
    39
    Sertraline treatment of patients with major depressive disorder who failed initial treatment with paroxetine or fluvoxamine
    4
    Pharmacy and medical costs associated with switching between venlafaxine and SSRI antidepressant therapy for the treatment of major depressive disorder.
    26
    Citalopram versus desipramine in treatment resistant depression: Effect of continuation or switching strategies. A randomized open study
    41
    Early Switching Strategies in Antidepressant Non-Responders: Current Evidence and Future Research Directions
    29
    Switching to duloxetine from selective serotonin reuptake inhibitors in non- or partial responders: Results from a Spanish sample
    3
    Pharmacological Interventions for Treatment-Resistant Depression in Adults
    3
    Escitalopram versus serotonin noradrenaline reuptake inhibitors as second step treatment for patients with major depressive disorder: a pooled analysis
    20
    Pharmacological treatment approaches to difficult-to-treat depression.
    1
    A critical review of pharmacotherapy for major depressive disorder.
    38

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 147 REFERENCES
    Dose escalation for insufficient response to standard-dose selective serotonin reuptake inhibitors in major depressive disorder: systematic review.
    57
    Partial response, nonresponse, and relapse with selective serotonin reuptake inhibitors in major depression: a survey of current "next-step" practices.
    134
    Strategies for Managing Depression Refractory to Selective Serotonin Reuptake Inhibitor Treatment: A Survey of Clinicians
    85
    Similar effectiveness of paroxetine, fluoxetine, and sertraline in primary care: a randomized trial.
    292
    Switching to bupropion in fluoxetine-resistant major depressive disorder.
    27
    Meta-analytical studies on new antidepressants.
    165
    Selective serotonin reuptake inhibitor discontinuation syndrome: a randomized clinical trial
    430
    Venlafaxine extended release versus conventional antidepressants in the remission of depressive disorders after previous antidepressant failure: ARGOS study
    66
    Fluoxetine treatment of patients with major depressive disorder who failed initial treatment with sertraline.
    183
    Combining antidepressants for treatment-resistant depression: a review.
    108